Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5900286 | Diabetes Research and Clinical Practice | 2012 | 6 Pages |
Abstract
In patients with diabetes and hypertriglyceridemia, a considerable discordance exists between non-HDL-C and Apo-B. Our data suggest a need for prospective studies to compare the relative merits of non-HDL-C and Apo-B targets in the assessment of cardiovascular risk.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
O.P. Ganda, C.G. Jumes, M.J. Abrahamson, M. Molla,